Endothelial cell-oligodendrocyte interactions in small vessel disease and aging

Clinical Science

Volumn 131, Issue 5, 2017, Pages 369-379

  Rajani, Rikesh M ^a   Williams, Anna ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CELL FUNCTION; CELL INTERACTION; CEREBROVASCULAR DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; VASCULARIZATION; WHITE MATTER; ANIMAL; CELL COMMUNICATION; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; CELL COMMUNICATION; CEREBRAL SMALL VESSEL DISEASES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; OLIGODENDROGLIA;

EID: 85014990090     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160618     Document Type: Review

References (116)

1. Baezner, H., Blahak, C., Poggesi, A., Pantoni, L., Inzitari, D., Chabriat, H., Erkinjuntti, T., Fazekas, F., Ferro, J.M., Langhorne, P. et al. (2008) Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 70, 935-942
2. Herrmann, L.L., Le Masurier, M. and Ebmeier, K.P. (2007) White matter hyperintensities in late life depression: a systematic review. J. Neurol. Neurosurg. Psychiatry 79, 619-624
3. de Laat, K.F., Tuladhar, A.M., van Norden, A.G., Norris, D.G., Zwiers, M.P. and de Leeuw, F.-E. (2011) Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease. Brain 134, 73-83
4. Prins, N.D., van Dijk, E.J., den Heijer, T., Vermeer, S.E., Jolles, J., Koudstaal, P.J., Hofman, A. and Breteler, M.M.B. (2005) Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128, 2034-2041
5. Smallwood, A., Oulhaj, A., Joachim, C., Christie, S., Sloan, C., Smith, A.D. and Esiri, M. (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the oxford project to investigate memory and ageing (OPTIMA) cohort. Neuropathol. Appl. Neurobiol. 38, 337-343
6. Bamford, J., Sandercock, P., Dennis, M., Burn, J. and Warlow, C. (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337, 1521-1526
7. Debette, S. and Markus, H.S. (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341, c3666
8. Esiri, M.M., Wilcock, G.K. and Morris, JH. (1997) Neuropathological assessment of the lesions of significance in vascular dementia. J. Neurol. Neurosurg. Psychiatry 63, 749-753
9. Verdelho, A., Madureira, S., Moleiro, C., Ferro, J.M., Santos, C.O., Erkinjuntti, T., Pantoni, L., Fazekas, F., Visser, M., Waldemar, G. et al. (2010) White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75, 160-167
10. Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Laurent, S., Lopez, O.L., Nyenhuis, D. et al. (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672-2713
11. Morris, Z., Whiteley, W.N., Longstreth, W.T., Weber, F., Lee, Y., Tsushima, Y., Alphs, H., Ladd, S.C., Warlow, C., Wardlaw, J.M. and Al-Shahi Salman, R. (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339, b3016
12. Vermeer, S.E., Longstreth, W.T. and Koudstaal, P.J. (2007) Silent brain infarcts: a systematic review. Lancet Neurol. 6, 611-619
13. Fisher, C.M. (1969) The arterial lesions underlying lacunes. Acta Neuropathol 12, 1-15
14. Lammie, G.A. (2000) Pathology of small vessel stroke. Br. Med. Bull. 56, 296-306
15. Wardlaw, J.M. (2008) What is a lacune? Stroke 39, 2921-2922
16. Gouw, A.A., Seewann, A., van der Flier, W.M., Barkhof, F., Rozemuller, A.M., Scheltens, P. and Geurts, J.J.G (2011) Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J. Neurol. Neurosurg. Psychiatry 82, 126-135
17. Schmidt, R., Schmidt, H., Haybaeck, J., Loitfelder, M., Weis, S., Cavalieri, M., Seiler, S., Enzinger, C., Ropele, S., Erkinjuntti, T. et al. (2011) Heterogeneity in age-related white matter changes. Acta Neuropathol. 122, 171-185
18. Lammie, G.A. (2002) Hypertensive cerebral small vessel disease and stroke. Brain Pathol. 12, 358-370
19. Wardlaw, J.M., Smith, E.E., Biessels, G.J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R.I., O'Brien, J.T., Barkhof, F., Benavente, O.R. et al. (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12, 822-838
20. Wardlaw, J.M., Smith, C. and Dichgans, M. (2013) Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 12, 483-497
21. Peters, A. (2007) Chapter 5. The effects of normal aging on nerve fibers and neuroglia in the central nervous system. In Brain Aging: Models, Methods, and Mechanisms (Riddle, D.R., ed.), pp. 97-125, CRC Press, Boca Raton
22. Ungvari, Z., Kaley, G., De Cabo, R., Sonntag, W.E. and Csiszar, A. (2010) Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65A, 1028-1041
23. Sonntag, W.E., Eckman, D.M., Ingraham, J. and Riddle, D.R. (2007) Chapter 12. Regulation of cerebrovascular aging. In Brain Aging: Models, Methods, and Mechanisms (Riddle, D.R., ed.), p. 279, CRC Press, Boca Raton
24. Latimer, C.S., Searcy, J.L., Bridges, M.T., Brewer, L.D., Popović, J., Blalock, E.M., Landfield, P.W., Thibault, O. and Porter, N.M. (2011) Reversal of glial and neurovascular markers of unhealthy brain aging by exercise in middle-aged female mice. PLoS One 6, e26812
25. Fukutake, T. (2011) Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. J. Stroke Cerebrovasc. Dis. 20, 85-93
26. Dawson, M.R., Polito, A., Levine, J.M. and Reynolds, R. (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci. 24, 476-488
27. Richardson, W.D., Young, K.M., Tripathi, R.B. and McKenzie, I. (2011) NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron 70, 661-673
28. Huxley, A.F. and Staümpfli, R. (1949) Saltatory transmission of the nervous impulse. Arch. Sci. Physiol. 3, 435-448
29. Tasaki, I. (1939) The electro-saltatory transmission of the nerve impulse and the effect of narcosis upon the nerve fiber. J. Physiol. 127, 211-227
30. Geren, B.B. and Schmitt, F.O. (1954) The structure of the Schwann cell and its relation to the axon in certain invertebrate nerve fibers. Proc. Natl. Acad. Sci. U.S.A. 40, 863-870
31. Saher, G., Bruügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R., Wehr, M.C., Wieland, F., Ishibashi, S. and Nave, K.-A. (2005) High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468-475
32. Linker, R.A., Lee, D.-H., Demir, S., Wiese, S., Kruse, N., Siglienti, I., Gerhardt, E., Neumann, H., Sendtner, M., Luühder, F. and Gold, R. (2010) Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133 Pt 8, 2248-2263
33. Wilkins, A., Chandran, S. and Compston, A. (2001) A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 36, 48-57
34. Lee, Y., Morrison, B.M., Li, Y., Lengacher, S., Farah, M.H., Hoffman, P.N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P. et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443-448
35. Fuünfschilling, U., Supplie, L.M., Mahad, D., Boretius, S., Saab, A.S., Edgar, J., Brinkmann, B.G., Kassmann, C.M., Tzvetanova, I.D., Möbius, W. et al. (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517-521
36. Hawkins, B. and Davis, T. (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173-185
37. Wolburg, H. and Lippoldt, A. (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337
38. Abbott, N.J., Rönnbaück, L. and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53
39. Cserr, H.F. and Bundgaard, M. (1984) Blood-brain interfaces in vertebrates: a comparative approach. Am. J. Physiol. 246, R277-R288
40. Hallbergson, A.F., Gnatenco, C. and Peterson, D.A. (2003) Neurogenesis and brain injury: managing a renewable resource for repair. J. Clin. Invest. 112, 1128-1133
41. y Cajal, S.R. (1928) Degeneration and regeneration of the nervous system., Oxford University Press, New York
42. Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S. and Tsukita, S. (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123, 1777-1788
43. Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K. and Tsukita, S. (1998) Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141, 1539-1550
44. Martìn-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C., Stoppacciaro, A., Ruco, L., Villa, A. et al. (1998) Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142, 117-127
45. Sohet, F., Lin, C., Munji, R.N., Lee, S.Y., Ruderisch, N., Soung, A., Arnold, T.D., Derugin, N., Vexler, Z.S., Yen, F.T. and Daneman, R. (2015) LSR/angulin-1 is a tricellular tight junction protein involved in blood-brain barrier formation. J. Cell Biol. 208, 703-711
46. Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M. and Tsukita, S. (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161, 653-660
47. Morita, K., Sasaki, H., Furuse, M. and Tsukita, S. (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147, 185-194
48. Tsukita, S., Katsuno, T., Yamazaki, Y., Umeda, K., Tamura, A. and Tsukita, S. (2009) Roles of ZO-1 and ZO-2 in establishment of the belt-like adherens and tight junctions with paracellular permselective barrier function. Ann. N.Y. Acad. Sci. 1165, 44-52
49. Nedergaard, M., Ransom, B. and Goldman, S.A. (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26, 523-530
50. Dermietzel, R., Spray, D.C. and Needergard, M. (2006) Blood-brain barriers: from ontogeny to artificial interfaces. vol. 1. (Dermietzel, R., Spray, D.C., Nedergaard, M., eds), vol. 1, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany
51. McAllister, M.S., Krizanac-Bengez, L., Macchia, F., Naftalin, R.J., Pedley, K.C., Mayberg, M.R., Marroni, M., Leaman, S., Stanness, K.A. and Janigro, D. (2001) Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain Res. 904, 20-30
52. Simpson, I.A. (2001) Glucose transporter asymmetries in the bovine blood-brain barrier. J. Biol. Chem. 276, 12725-12729
53. Muller, W.A. (2011) Mechanisms of leukocyte transendothelial migration. Annu. Rev. Pathol. 6, 323-344
54. Smith, C.W., Rothlein, R., Hughes, B.J., Mariscalco, M.M., Rudloff, H.E., Schmalstieg, F.C. and Anderson, D.C. (1988) Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J. Clin. Invest. 82, 1746-1756
55. Mooradian, D.L., Hutsell, T.C. and Keefer, L.K. (1995) Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol. 25, 674-678
56. Radomski, M.W., Palmer, R.M. and Moncada, S. (1991) Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol. Sci. 12, 87-88
57. Lip, P.L., Belgore, F., Blann, A.D., Hope-Ross, M.W., Gibson, J.M. and Lip, G.Y. (2000) Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Investig. Ophthalmol. Vis. Sci. 41, 2115-2159
58. Pearson, J.D. (2000) Normal endothelial cell function. Lupus 9, 183-188
59. Rajashekhar, G., Willuweit, A., Patterson, C.E., Sun, P., Hilbig, A., Breier, G., Helisch, A. and Clauss, M. (2006) Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J. Vasc. Res. 43, 193-204
60. Grammas, P. (2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J. Neuroinflammation 8, 26
61. Najjar, S., Pearlman, D.M., Devinsky, O., Najjar, A. and Zagzag, D. (2013) Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J. Neuroinflammation 10, 142
62. Staddon, J.M. and Rubin, L.L. (1996) Cell adhesion, cell junctions and the blood-brain barrier. Curr. Opin. Neurobiol. 6, 622-627
63. Vandenbroucke, E., Mehta, D., Minshall, R. and Malik, A.B. (2008) Regulation of endothelial junctional permeability. Ann. N.Y. Acad. Sci. 1123, 134-145
64. Farrall, A.J. and Wardlaw, J.M. (2009) Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol. Aging 30, 337-352
65. Poggesi, A., Pasi, M., Pescini, F., Pantoni, L. and Inzitari, D. (2015) Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J. Cereb. Blood Flow Metab. 36, 72-94
66. Hassan, A., Hunt, B.J., O'Sullivan, M., Parmar, K., Bamford, J.M., Briley, D., Brown, M.M., Thomas, D.J. and Markus, H.S. (2003) Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 126, 424-432
67. Wiseman, S., Marlborough, F., Doubal, F., Webb, D.J. and Wardlaw, J. (2013) Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc. Dis. 37, 64-75
68. Markus, H.S., Hunt, B., Palmer, K., Enzinger, C., Schmidt, H. and Schmidt, R. (2005) Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian stroke prevention study. Stroke 36, 1410-1414
69. Elbaz, A., Poirier, O., Moulin, T., Chédru, F., Cambien, F. and Amarenco, P. (2000) Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. The GENIC investigators. Stroke 31, 1634-1639
70. Hassan, A., Gormley, K., O'Sullivan, M., Knight, J., Sham, P., Vallance, P., Bamford, J. and Markus, H. (2004) Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35, 654-659
71. Hainsworth, A.H. and Markus, H.S. (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J. Cereb. Blood Flow Metab. 28, 1877-1891
72. Bailey, E.L., McCulloch, J., Sudlow, C. and Wardlaw, J.M. (2009) Potential animal models of lacunar stroke: a systematic review. Stroke 40, e451-e458
73. Bailey, E.L., Smith, C., Sudlow, C.L. and Wardlaw, J.M. (2011) Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review. Int. J. Stroke 6, 434-444
74. Yamori, Y. and Horie, R. (1977) Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 8, 456-461
75. Lin, J.X., Tomimoto, H., Akiguchi, I., Wakita, H., Shibasaki, H. and Horie, R. (2001) White matter lesions and alteration of vascular cell composition in the brain of spontaneously hypertensive rats. Neuroreport 12, 1835-1839
76. Yamori, Y., Horie, R., Handa, H., Sato, M. and Fukase, M. (1976) Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7, 46-53
77. Bailey, E.L., McBride, M.W., Crawford, W., McClure, J.D., Graham, D., Dominiczak, A.F., Sudlow, C.L.M., Smith, C. and Wardlaw, J.M. (2014) Differential gene expression in multiple neurological, inflammatory and connective tissue pathways in a spontaneous model of human small vessel stroke. Neuropathol. Appl. Neurobiol. 40, 855-872
78. Holland, P.R., Searcy, J.L., Salvadores, N., Scullion, G., Chen, G., Lawson, G., Scott, F., Bastin, M.E., Ihara, M., Kalaria, R. et al. (2015) Gliovascular disruption and cognitive deficits in a mouse model with features of small vessel disease. J. Cereb. Blood Flow Metab. 35, 1005-1014
79. Reimer, M.M., McQueen, J., Searcy, L., Scullion, G., Zonta, B., Desmazieres, A., Holland, P.R., Smith, J., Gliddon, C., Wood, E.R. et al. (2011) Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J. Neurosci. 31, 18185-18194
80. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Marechal, E. et al. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710
81. Joutel, A., Monet-Leprêtre, M., Gosele, C., Baron-Menguy, C., Hammes, A., Schmidt, S., Lemaire-Carrette, B., Domenga, V., Schedl, A., Lacombe, P. and Hubner, N. (2010) Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J. Clin. Invest. 120, 433-445
82. Monet-Leprêtre, M., Haddad, I., Baron-Menguy, C., Fouillot-Panchal, M., Riani, M., Domenga-Denier, V., Dussaule, C., Cognat, E., Vinh, J. and Joutel, A. (2013) Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. Brain 136, 1830-1845
83. Capone, C., Cognat, E., Ghezali, L., Baron-Menguy, C., Aubin, D., Mesnard, L., Stöhr, H., Domenga-Denier, V., Nelson, M.T. and Joutel, A. (2015) Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice. Ann. Neurol. 79, 387-403
84. Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N. et al. (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929-11947
85. Pöschl, E., Schlötzer-Schrehardt, U., Brachvogel, B., Saito, K., Ninomiya, Y. and Mayer, U. (2004) Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131, 1619-1628
86. Gould, D.B., Phalan, F.C., van Mil, S.E., Sundberg, J.P., Vahedi, K., Massin, P., Bousser, M.G., Heutink, P., Miner, J.H., Tournier-Lasserve, E. and John, S.W.M. (2006) Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N. Engl. J. Med. 354, 1489-1496
87. Verbeek, E., Meuwissen, M.E., Verheijen, F.W., Govaert, P.P., Licht, D.J., Kuo, D.S., Poulton, C.J., Schot, R., Lequin, M.H., Dudink, J. et al. (2012) COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur. J. Hum. Genet. 20, 844-851
88. Hara, K., Shiga, A., Fukutake, T., Nozaki, H., Miyashita, A., Yokoseki, A., Kawata, H., Koyama, A., Arima, K., Takahashi, T. et al. (2009) Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N. Engl. J. Med. 360, 1729-1739
89. Nozaki, H., Nishizawa, M. and Onodera, O. (2014) Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 45, 3447-3453
90. Oide, T., Nakayama, H., Yanagawa, S., Ito, N., Ikeda, S.I. and Arima, K. (2008) Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Neuropathology 28, 132-142
91. Beaufort, N., Scharrer, E., Kremmer, E., Lux, V., Ehrmann, M., Huber, R., Houlden, H., Werring, D., Haffner, C. and Dichgans, M. (2014) Cerebral small vessel disease-related protease HtrA1 processes latent TGFβ binding protein 1 and facilitates TGF-β signaling. Proc. Natl. Acad. Sci. U.S.A. 111, 16496-16501
92. Shiga, A., Nozaki, H., Yokoseki, A., Nihonmatsu, M., Kawata, H., Kato, T., Koyama, A., Arima, K., Ikeda, M., Katada, S. et al. (2011) Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1. Hum. Mol. Genet. 20, 1800-1810
93. Schini, V.B., Durante, W., Elizondo, E., Scott-Burden, T., Junquero, D.C., Schafer, A.I. and Vanhoutte, P.M. (1992) The induction of nitric oxide synthase activity is inhibited by TGF-β1, PDGFAB and PDGFBB in vascular smooth muscle cells. Eur. J. Pharmacol. 216, 379-383
94. Shimizu, F., Sano, Y., Tominaga, O., Maeda, T., Abe, M.-A. and Kanda, T. (2013) Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro. Neurobiol. Aging 34, 1902-1912
95. Arai, K. and Lo, E.H. (2009) An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells. J. Neurosci. 29, 4351-4355
96. Leventhal, C., Rafii, S., Rafii, D., Shahar, A. and Goldman, S.A. (1999) Endothelial trophic support of neuronal production and recruitment from the adult mammalian subependyma. Mol. Cell Neurosci. 13, 450-464
97. Palmer, T.D., Willhoite, A.R. and Gage, F.H. (2000) Vascular niche for adult hippocampal neurogenesis. J. Comp. Neurol. 425, 479-494
98. Kurachi, M., Mikuni, M. and Ishizaki, Y. (2016) Extracellular vesicles from vascular endothelial cells promote survival, proliferation and motility of oligodendrocyte precursor cells. PLoS One 11, e0159158
99. Mayes, D.A., Rizvi, T.A., Titus-Mitchell, H., Oberst, R., Ciraolo, G.M., Vorhees, C.V., Robinson, A.P., Miller, S.D., Cancelas, J.A., Stemmer-Rachamimov, A.O. and Ratner, N. (2013) Nf1 Loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defeCts in myelin and vasculature. Cell Rep. 4, 1197-1212
100. Seo, J.H., Maki, T., Maeda, M., Miyamoto, N., Liang, A.C., Hayakawa, K., Pham, L.-D.D., Suwa, F., Taguchi, A., Matsuyama, T. et al. (2014) Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling. PLoS One 9, e103174
101. Seo, J.H., Miyamoto, N., Hayakawa, K., Pham, L.-D.D., Maki, T., Ayata, C., Kim, K.-W., Lo, E.H. and Arai, K. (2013) Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J. Clin. Invest. 123, 782-786
102. Pham, L.D., Hayakawa, K., Seo, J.H., Nguyen, M.N., Som, A.T., Lee, B.J., Guo, S., Kim, K.W., Lo, E.H. and Arai, K. (2012) Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury. Glia 60, 875-881
103. Tsai, H.-H., Niu, J., Munji, R., Davalos, D., Chang, J., Zhang, H., Tien, A.-C., Kuo, C.J., Chan, J.R., Daneman, R. and Fancy, S.P.J. (2016) Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science 351, 379-384
104. Yuen, T.J., Silbereis, J.C., Griveau, A., Chang, S.M., Daneman, R., Fancy, S.P.J., Zahed, H., Maltepe, E. and Rowitch, D.H. (2014) Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell 158, 383-396
105. Cayre, M., Courtès, S., Martineau, F., Giordano, M., Arnaud, K., Zamaron, A. and Durbec, P. (2013) Netrin 1 contributes to vascular remodeling in the subventricular zone and promotes progenitor emigration after demyelination. Development 140, 3107-3117
106. Roscoe, W.A., Welsh, M.E., Carter, D.E. and Karlik, S.J. (2009) VEGF and angiogenesis in acute and chronic MOG (35-55) peptide induced EAE. J. Neuroimmunol. 209, 6-15
107. Holley, J.E., Newcombe, J., Whatmore, J.L. and Gutowski, N.J. (2010) Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci. Lett. 470, 65-70
108. Ludwin, S.K., Henry, J.M. and McFarland, H. (2001) Vascular proliferation and angiogenesis in multiple sclerosis: clinical and pathogenetic implications. J. Neuropathol. Exp. Neurol. 60, 505
109. Korn, J., Christ, B. and Kurz, H. (2002) Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J. Comp. Neurol. 442, 78-88
110. Daneman, R., Zhou, L., Kebede, A.A. and Barres, B.A. (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566
111. Ramsauer, M., Krause, D. and Dermietzel, R. (2016) Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes. FASEB J. 16, 1274-1276
112. Maki, T., Maeda, M., Uemura, M., Lo, E.K., Terasaki, Y., Liang, A.C., Shindo, A., Choi, Y.K., Taguchi, A., Matsuyama, T. et al. (2015) Potential interactions between pericytes and oligodendrocyte precursor cells in perivascular regions of cerebral white matter. Neurosci. Lett. 597, 164-169
113. Takano, T., Tian, G.-F., Peng, W., Lou, N., Libionka, W., Han, X. and Nedergaard, M. (2006) Astrocyte-mediated control of cerebral blood flow. Nat. Neurosci. 9, 260-267
114. Arai, K. and Lo, E.H. (2010) Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling. J. Neurosci. Res. 88, 758-763
115. Meyer, J., Rauh, J. and Galla, H.J. (1991) The susceptibility of cerebral endothelial cells to astroglial induction of blood-brain barrier enzymes depends on their proliferative state. J. Neurochem. 57, 1971-1977
116. Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Van Bruggen, N. and Chopp, M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838